Correction: Loss of EGFR Signaling-Regulated Mir-203 Promotes Prostate Cancer Bone Metastasis and Tyrosine Kinase Inhibitors Resistance

Man Kit Siu,Wassim Abou-Kheir,Juan,Yung-Chieh Chang,Ben Barrett,Florent Suau,Órla Casey,Wei-Yu Chen,Lei Fang,Paul G. Hynes,Yao-Yu Hsieh,Yen-Nien Liu,Jiaoti Huang,Kathleen Kelly

DOI: https://doi.org/10.18632/oncotarget.26020

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.1994.].

What problem does this paper attempt to address?

Correction: PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder Through Sponging Mir-30C to Induce Epithelial–Mesenchymal Transition

Xin Chen,Rixin Chen,Wensu Wei,Yonghong Li,Zhaoyong Feng,Liang Tan,Jie-Wei Chen,Yuan Gang,Siliang Chen,Shengjie Guo,Kai Xiao,Zhuowei Liu,Junhang Luo,Fangjian Zhou,Dan Xie

DOI: https://doi.org/10.1158/1078-0432.ccr-21-0936

IF: 13.801

2021-01-01

Clinical Cancer Research

Abstract:In the original version of [this article][1] ([1][2]), an incorrect image was used for the p-control cells in Fig. 2F. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret the error. 1. 1.[↵][3]1. Chen X, 2. Chen R-X, 3. Wei W-S
Correction: Infiltrating Mast Cells Increase Prostate Cancer Chemotherapy and Radiotherapy Resistances Via Modulation of P38/p53/p21 and ATM Signals.

Hongjun Xie,Chong Li,Qiang Dang,Luke S Chang,Lei Li

DOI: https://doi.org/10.18632/oncotarget.27023

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.6372.].
Correction: Overexpression of Wildtype EGFR is Tumorigenic and Denotes a Therapeutic Target in Non-Small Cell Lung Cancer

Naiqing Xu,Wenfeng Fang,Libing Mu,Yanna Tang,Lei Gao,Shengxiang Ren,Dengfeng Cao,Lei Zhou,Aiqun Zhang,Deruo Liu,Caicun Zhou,Kwok-Kin Wong,Lei Yu,Li Zhang,Chaozhao Liang

DOI: https://doi.org/10.18632/oncotarget.26254

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.6461.].
Erratum: Loss of E-cadherin promotes prostate cancer metastasis via upregulation of metastasis-associated gene 1 expression.

Liangsheng Fan,Hongyan Wang,Xi Xia,Yumei Rao,Xiangyi Ma,Ding Ma,Peng Wu,Gang Chen

DOI: https://doi.org/10.3892/ol.2020.11421

2020-01-01

Oncology Letters

Abstract:[This corrects the article DOI: 10.3892/ol.2012.934.].
Corrigendum: Long Non-Coding RNA MIR570MG Causes Regorafenib Resistance in Colon Cancer by Repressing Mir-145/Smad3 Signaling

Fang Wei,Mofei Wang,Zhen Li,Yong Wang,Yong Zhou

DOI: https://doi.org/10.3389/fonc.2021.818876

IF: 4.7

2022-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.00291.].
Mir-365A-3p Regulates ADAM10-JAK-STAT Signaling to Suppress the Growth and Metastasis of Colorectal Cancer Cells: Erratum

Yong-Gang Hong,Cheng Xin,Ji-Dian Zhou,Xian-Hua Gao,Lun Hao,Qi-Zhi Liu,Wei Zhang,Li-Qiang Hao

DOI: https://doi.org/10.7150/jca.79828

IF: 3.9

2023-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.42731.].
Correction: Corrigendum: Overexpression of Mirna-497 Inhibits Tumor Angiogenesis by Targeting VEGFR2

Tu, Yingfeng,Liu, Li,Zhao, Dongliang,Liu, Youbin,Ma, Xiaowei,Fan, Yuhua,Wan, Lin,Huang, Tao,Cheng, Zhen,Shen, Baozhong

DOI: https://doi.org/10.1038/srep21221

IF: 4.6

2016-01-01

Scientific Reports

Abstract:Scientific Reports 5: Article number: 13827; published online: 08 September 2015; updated: 16 February 2016. In this Article, Figure 4 is incorrect. The correct Figure 4 appears below as Figure 1.
Correction: A Novel Highly Potent Trivalent TGF-β Receptor Trap Inhibits Early-Stage Tumorigenesis and Tumor Cell Invasion in Murine Pten-deficient Prostate Glands

Tai Qin,Lindsey Barron,Lu Xia,Haojie Huang,Maria M. Villarreal,John Zwaagstra,Cathy Collins,Junhua Yang,Christian Zwieb,Ravindra Kodali,Cynthia S. Hinck,Sun Kyung Kim,Robert L. Reddick,Chang Shu,Maureen D. O'Connor-McCourt,Andrew P. Hinck,Lu-Zhe Sun

DOI: https://doi.org/10.18632/oncotarget.13343

2016-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.13343.].
Correction: Publisher Correction: Simultaneous Overactivation of Wnt/β-catenin and TGFβ Signalling by Mir-128-3p Confers Chemoresistance-Associated Metastasis in NSCLC

Junchao Cai,Lishan Fang,Yongbo Huang,Rong Li,Xiaonan Xu,Zhihuang Hu,Le Zhang,Yi Yang,Xun Zhu,Heng Zhang,Jueheng Wu,Yan Huang,Jun Li,Musheng Zeng,Erwei Song,Yukai He,Li Zhang,Mengfeng Li

DOI: https://doi.org/10.1038/ncomms16196

IF: 16.6

2018-01-01

Nature Communications

Abstract:Nature Communications 8: Article number: 15870 (2017); Published online 19 June 2017; Updated 30 March 2018 In the original version of this Article, the affiliation details for Yan Huang and Li Zhang were incorrectly given as ‘Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China’, and should have been ‘State Key Laboratory of Oncology in South China, Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China’.
Correction: Clinical Significance and Effect of AEG-1 on the Proliferation, Invasion, and Migration of NSCLC: a Study Based on Immunohistochemistry, TCGA, Bioinformatics, in Vitro and in Vivo Verification.

Yu Zhang,Zu-Yun Li,Xin-Xi Hou,Xiao Wang,Yi-Huan Luo,Yan-Ping Ying,Gang Chen

DOI: https://doi.org/10.18632/oncotarget.28212

2022-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14972.].
Correction: Tumor Driven by Gain-of-function HER2 H878Y Mutant is Highly Sensitive to HER2 Inhibitor.

Zexi Hu,Yong Hu,Xicheng Liu,Rongwen Xi,Aiqun Zhang,Deruo Liu,Qiang Xie,Liang Chen

DOI: https://doi.org/10.18632/oncotarget.26252

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.5221.].
Author correction to ‘VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity’ [Acta Pharm Sin B11 (2021) 420–433]

Pengzhao Shang,Rui Gao,Yijia Zhu,Xiaorui Zhang,Yang Wang,Minji Guo,Hui Peng,Min Wang,Juan Zhang

DOI: https://doi.org/10.1016/j.apsb.2024.02.014

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2020.09.008.].
Corrigendum: Negatively Regulated by Mir-29C-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma Via the AMPK/mTOR Signalling Pathway.

Yongmeng Li,Yanfei Liu,Kai Jin,Rui Dong,Cun Gao,Libo Si,Zitong Feng,Huiying Zhang,Hui Tian

DOI: https://doi.org/10.3389/fcell.2022.870313

IF: 5.5

2022-01-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.771824.].
Correction: Up-Regulation of 91H Promotes Tumor Metastasis and Predicts Poor Prognosis for Patients with Colorectal Cancer.

Qiwen Deng,Bangshun He,Tianyi Gao,Yuqin Pan,Huiling Sun,Yeqiong Xu,Rui Li,Houqun Ying,Feng Wang,Xian Liu,Jie Chen,Shukui Wang

DOI: https://doi.org/10.1371/journal.pone.0304249

IF: 3.7

2024-01-01

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0103022.].
Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer

Lin Wang,Xiang-Bo Ji,Li-Hong Wang,Jian-Ge Qiu,Feng-Mei Zhou,Wen-Jing Liu,Di-di Wan,Marie Chai-mi Lin,Ling-Zhi Liu,Jian-Ying Zhang,Bing-Hua Jiang

DOI: https://doi.org/10.3389/fcell.2022.1008088

IF: 5.5

2022-09-23

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2020.00840.].

cell biology,developmental biology
Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum

Jiang-Kai Dong,Hui-Min Lei,Qian Liang,Ya-Bin Tang,Ye Zhou,Yang Wang,Shengzhe Zhang,Wen-Bin Li,Yunguang Tong,Guanglei Zhuang,Liang Zhang,Hong-Zhuan Chen,Liang Zhu,Ying Shen

DOI: https://doi.org/10.7150/thno.58558

IF: 11.6

2021-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.23177.].

medicine, research & experimental
Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.

Xinpei Yu,Junkui Ai,Liquan Cai,Yifeng Jing,Dan Wang,Jun Dong,Laura E Pascal,Jian Zhang,Rongcheng Luo,Zhou Wang

DOI: https://doi.org/10.18632/oncotarget.27354

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.8588.].
Correction: Real-world Management of Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small-cell Lung Cancer in the USA

Yulin Li,Anita Appius,Thirupathi Pattipaka,Andrea Feyereislova,Adrian Cassidy,Apar Kishor Ganti

DOI: https://doi.org/10.1371/journal.pone.0212831

IF: 3.7

2019-01-01

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0209709.].
Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Xin Tian,Lina Wu,Min Jiang,Zhenyong Zhang,Rong Wu,Jianing Miao,Caigang Liu,Song Gao

DOI: https://doi.org/10.3389/fonc.2022.793448

IF: 4.7

2022-04-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.641399.].

oncology
Erratum: MicroRNA-181 inhibits the proliferation, drug sensitivity and invasion of human glioma cells by targeting Selenoprotein K (SELK).

Chun-Hua Xu,Li-Min Xiao,Er-Ming Zeng,Li-Ke Chen,Su-Yue Zheng,Dong-Hai Li,Yue Liu

2021-01-01

American journal of translational research

Abstract:[This corrects the article on p. 6632 in vol. 11, PMID: 31737213.].

Correction: Loss of EGFR Signaling-Regulated Mir-203 Promotes Prostate Cancer Bone Metastasis and Tyrosine Kinase Inhibitors Resistance

Correction: PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder Through Sponging Mir-30C to Induce Epithelial–Mesenchymal Transition

Correction: Infiltrating Mast Cells Increase Prostate Cancer Chemotherapy and Radiotherapy Resistances Via Modulation of P38/p53/p21 and ATM Signals.

Correction: Overexpression of Wildtype EGFR is Tumorigenic and Denotes a Therapeutic Target in Non-Small Cell Lung Cancer

Erratum: Loss of E-cadherin promotes prostate cancer metastasis via upregulation of metastasis-associated gene 1 expression.

Corrigendum: Long Non-Coding RNA MIR570MG Causes Regorafenib Resistance in Colon Cancer by Repressing Mir-145/Smad3 Signaling

Mir-365A-3p Regulates ADAM10-JAK-STAT Signaling to Suppress the Growth and Metastasis of Colorectal Cancer Cells: Erratum

Correction: Corrigendum: Overexpression of Mirna-497 Inhibits Tumor Angiogenesis by Targeting VEGFR2

Correction: A Novel Highly Potent Trivalent TGF-β Receptor Trap Inhibits Early-Stage Tumorigenesis and Tumor Cell Invasion in Murine Pten-deficient Prostate Glands

Correction: Publisher Correction: Simultaneous Overactivation of Wnt/β-catenin and TGFβ Signalling by Mir-128-3p Confers Chemoresistance-Associated Metastasis in NSCLC

Correction: Clinical Significance and Effect of AEG-1 on the Proliferation, Invasion, and Migration of NSCLC: a Study Based on Immunohistochemistry, TCGA, Bioinformatics, in Vitro and in Vivo Verification.

Correction: Tumor Driven by Gain-of-function HER2 H878Y Mutant is Highly Sensitive to HER2 Inhibitor.

Author correction to ‘VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity’ [Acta Pharm Sin B11 (2021) 420–433]

Corrigendum: Negatively Regulated by Mir-29C-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma Via the AMPK/mTOR Signalling Pathway.

Correction: Up-Regulation of 91H Promotes Tumor Metastasis and Predicts Poor Prognosis for Patients with Colorectal Cancer.

Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer

Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum

Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.

Correction: Real-world Management of Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small-cell Lung Cancer in the USA

Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Erratum: MicroRNA-181 inhibits the proliferation, drug sensitivity and invasion of human glioma cells by targeting Selenoprotein K (SELK).